CT/MR LI-RADS 2018: clinical implications and management recommendations

Amita Kamath, Alexandra Roudenko, Elizabeth Hecht, Claude Sirlin, Victoria Chernyak, Kathryn Fowler, Donald G. Mitchell

Research output: Contribution to journalReview article

6 Scopus citations

Abstract

Unique among solid organ tumors, hepatocellular carcinoma (HCC), may be diagnosed by imaging alone, without the need for biopsy. The Liver Imaging Reporting and Data System (LI-RADS) was developed to provide high-specificity diagnosis of HCC based on imaging while also standardizing the assessment and reporting of the entire spectrum of lesions and pseudolesions encountered in patients at risk for this malignancy. In this pictorial review, we discuss management recommendations associated with CT/MR LI-RADS observations. We emphasize the rationale for the recommendations and the role of multidisciplinary management discussion, and we provide a framework for standardized reporting. Management of patients who undergo ultrasound (US) for screening and surveillance or those who undergo diagnostic contrast-enhanced ultrasound (CEUS) is beyond the scope of this paper.

Original languageEnglish (US)
Pages (from-to)1306-1322
Number of pages17
JournalAbdominal Radiology
Volume44
Issue number4
DOIs
StatePublished - Apr 1 2019

Keywords

  • HCC
  • Imaging
  • LI-RADS
  • Standardized reporting

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology
  • Radiology Nuclear Medicine and imaging
  • Gastroenterology
  • Urology

Fingerprint Dive into the research topics of 'CT/MR LI-RADS 2018: clinical implications and management recommendations'. Together they form a unique fingerprint.

  • Cite this

    Kamath, A., Roudenko, A., Hecht, E., Sirlin, C., Chernyak, V., Fowler, K., & Mitchell, D. G. (2019). CT/MR LI-RADS 2018: clinical implications and management recommendations. Abdominal Radiology, 44(4), 1306-1322. https://doi.org/10.1007/s00261-018-1868-6